Coronary Disease News and Research

RSS

Study finds TAVR to be as good as open-heart surgery for patients at low surgical risk

A new trial comparing self-expanding transcatheter aortic valve replacement (TAVR) to standard open-heart surgery for valve replacement—this time in patients with severe aortic stenosis who are considered low surgical risk—found no difference in the combined rate of disabling stroke or death from any cause at two years.

18 Mar 2019

Nano therapy reverses deadliest effects of chronic kidney disease in animal model

By loading a chelation drug into a nano-sized homing device, researchers at Clemson University have reversed in an animal model the deadliest effects of chronic kidney disease, which kills more people in the United States each year than breast or prostate cancer.

5 Mar 2019

New insights into peripartum cardiomyopathy in women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 403-408(6); DOI: ttps://doi.org/10.15212/CVIA.2017.0066 Dmitry Yaranov, MD and Jeffrey D. Alexis, MD from the College of Medicine, University of Florida, Jacksonville, FL, USA and the University of Rochester, Rochester, NY, USA consider peripartum cardiomyopathy.

2 Mar 2019

Flaws and limitations in cardiovascular risk prediction and stratification in women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 329-348(20); DOI: https://doi.org/10.15212/CVIA.2017.0068 Sonia Henry, MD, Rachel Bond, MD, Stacey Rosen, MD, Cindy Grines, MD and Jennifer Mieres, MD from the Hofstra School of Medicine, Manhasset, NY, USA, Lenox Hill Hospital, New York, NY, USA and The Katz Institute for Women's Health, Lake Success, NY, USA consider the challenges in cardiovascular risk prediction and stratification in women.

2 Mar 2019

$Evaluation and management of heart failure with preserved ejection fraction in women$

Evaluation and management of heart failure with preserved ejection fraction in women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 409-420(12); DOI: https://doi.org/10.15212/CVIA.2017.0062 Juan R. Vilaro, MD, Mustafa Ahmed, MD and Juan M. Aranda Jr. MD from the Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA consider heart failure with preserved ejection fraction.

2 Mar 2019

Risk factors and noninvasive diagnostic assessment of NOCAD in women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 349-361(13); DOI: https://doi.org/10.15212/CVIA.2017.0077 Keith C. Ferdinand, MD and Rohan Samson, MD from the Tulane University Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA, USA consider nonobstructive coronary artery disease in women: risk factors and noninvasive diagnostic assessment.

1 Mar 2019

Relationship between circadian misalignment and cardiovascular risk in women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 435-440(6); DOI: https://doi.org/10.15212/CVIA.2017.0070 Tracy Ashby, DO and Mariam Louis, MD, MSc, FCCP from the University of Florida, Department of Medicine, Jacksonville, FL, USA consider circadian misalignment and cardiovascular risk.

1 Mar 2019

Experts provide detailed review of antiplatelet therapy considerations in women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 363-373(11); DOI: https://doi.org/10.15212/CVIA.2017.0079 Khadeeja Esmail and Dominick J. Angiolillo from the University of Florida Medical School, Gainesville, FL, USA review antiplatelet therapy considerations in women.

1 Mar 2019

Noninvasive imaging tools to detect stable ischemic heart disease in women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 375-389(15); DOI: https://doi.org/10.15212/CVIA.2019.0007 Viviany R. Taqueti from the Cardiovascular Imaging Program, Heart and Vascular Center, Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA reviews novel imaging approaches for the diagnosis of stable ischemic heart disease in women.

1 Mar 2019

Association between OSA and cardiovascular diseases in women

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P. Velarde) pp. 421-434(14); DOI https://doi.org/10.15212/CVIA.2017.0064, Nimeh Najjar, MD, Peter Staiano, MD and Mariam Louis, MD from the University of Florida, Department of Medicine, Jacksonville, FL, USA consider obstructive sleep apnea and cardiovascular disease in women.

28 Feb 2019

Study findings can help develop new drugs for ischemia

Russian scientists investigated the role of opioid receptors in protecting the heart from coronary disease: the lack of its blood supply.

25 Feb 2019

Research finds reasons for sudden cardiac death in patients with stable ischemic disease

Sudden death in patients with stable ischemic heart disease is not a common occurrence and is sparsely reported.

18 Feb 2019

Anti-inflammatory biologic therapy may prevent heart disease in patients with skin condition

Anti-inflammatory biologic drugs used to treat severe psoriasis have the potential to prevent heart disease in patients with the skin condition, according to research published today in Cardiovascular Research, a journal of the European Society of Cardiology.

5 Feb 2019

Study finds sex-specific differences in mechanisms that drive stress-induced myocardial ischemia

Some patients with coronary artery disease have inadequate blood flow to the heart muscle during periods of mental/emotional stress.

27 Nov 2018

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

When it comes to reducing inflammation to decrease the risk of heart disease and stroke, results from the much-anticipated Cardiovascular Inflammation Reduction Trial indicate that targeting the right inflammatory pathways in at-risk patients is crucial.

12 Nov 2018

Genetic score helps predict future major coronary events, shows study

Coronary artery disease (CAD) is the leading killer of people with type 2 diabetes, and it's not a secret killer.

28 Sep 2018

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival, myocardial infarction and stroke after an episode of worsening heart failure in patients with heart failure, sinus rhythm, and coronary artery disease, according to late breaking results from the COMMANDER HF trial presented today in a Hot Line Session at ESC Congress 2018 and with simultaneous publication in NEJM.

27 Aug 2018

New reagents added to the CLC800 and CLC1500 clinical analyzers

Carolina Liquid Chemistries Corp. have recently added three moderately complex reagents to the CLC800 and the CLC1600 clinical chemistry analyzers.

From Carolina Liquid Chemistries Corp. 23 Aug 2018

Sex hormone levels linked to higher risk of heart disease in post-menopausal women

In post-menopausal women, having a higher blood level of a male hormone (testosterone) and a higher ratio of the male-type to-female type (estrogen) of hormones is associated with a higher risk of heart disease later in life, according to research published today in the Journal of the American College of Cardiology.

28 May 2018

Common therapy options for psoriasis can help reduce coronary plaque, study shows

Late-breaking clinical science shows common therapy options for psoriasis (PSO)-a chronic inflammatory skin disease-can help reduce coronary plaque. The authors found that not only do the treatments reduce the volume of the plaque, but also the plaque becomes less inflammatory over time harboring fewer characteristics prone to rupture and cause a heart attack.

26 Apr 2018

Coronary Disease News and Research

Study finds TAVR to be as good as open-heart surgery for patients at low surgical risk

Nano therapy reverses deadliest effects of chronic kidney disease in animal model

New insights into peripartum cardiomyopathy in women

Flaws and limitations in cardiovascular risk prediction and stratification in women

Evaluation and management of heart failure with preserved ejection fraction in women

Risk factors and noninvasive diagnostic assessment of NOCAD in women

Relationship between circadian misalignment and cardiovascular risk in women

Experts provide detailed review of antiplatelet therapy considerations in women

Noninvasive imaging tools to detect stable ischemic heart disease in women

Association between OSA and cardiovascular diseases in women

Study findings can help develop new drugs for ischemia

Research finds reasons for sudden cardiac death in patients with stable ischemic disease

Anti-inflammatory biologic therapy may prevent heart disease in patients with skin condition

Study finds sex-specific differences in mechanisms that drive stress-induced myocardial ischemia

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

Genetic score helps predict future major coronary events, shows study

Antithrombin drug does not reduce risk of myocardial infarction, stroke in heart failure patients

New reagents added to the CLC800 and CLC1500 clinical analyzers

Sex hormone levels linked to higher risk of heart disease in post-menopausal women

Common therapy options for psoriasis can help reduce coronary plaque, study shows

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News